Gentech Holdings Inc (GTEH) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Gentech Holdings Inc $0.00, price $0.00, upside +100.0%, quality 29 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Gentech Holdings Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
GenTech Holdings, Inc. operates a chain of hemp centric coffee shop retail spaces under the Healthy Leaf brand name. The company offers CBD-infused chocolates, skin creams, artisan teas, artisan coffee, wellness snack bars, and pet treats through its retail spaces. It also provides holistic education and classes.
Show more
GenTech Holdings, Inc. operates a chain of hemp centric coffee shop retail spaces under the Healthy Leaf brand name. The company offers CBD-infused chocolates, skin creams, artisan teas, artisan coffee, wellness snack bars, and pet treats through its retail spaces. It also provides holistic education and classes. The company was founded in 2013 and is based in New York, New York.
Stock analysis
Gentech Holdings Inc (GTEH) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0002, implying the stock looks roughly 50.0% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 87/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 29/100 (below-average quality), in the Consumer Cyclical sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Gentech Holdings Inc reported revenue of $909K in FY2021 versus $203K in FY2016, a compound +34.9%/yr. Reported net income was −$4.3M in FY2021.
Key figures
Market cap $610 · EPS (TTM) $−12.68 · Return on assets (EBIT) −6,970% · Free cash flow −$7.9M · Net debt $888K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
The share trades about 100% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −19% fair-value upside, at 100%, GTEH screens cheaper than that median.
Fair Value models
Bear $0.0002Fair Value $0.0002Bull $0.0002
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+259.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+64.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.9%
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+233.1%
’13
’14
’15
’16
’18
’20
’21
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−667.8% (2016) → −650.3% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2021 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Restaurants · 207 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Gentech Holdings Inc (GTEH) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0002 versus a price of $0.0001, about +100% upside (undervalued).
What is the fair value of GTEH?
Our model-based fair value for Gentech Holdings Inc is $0.0002 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0001.
What is the quality score of GTEH?
Gentech Holdings Inc has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Gentech Holdings Inc (GTEH)?
Our model-based price target is the fair value of $0.0002 (as of Sep 27, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Gentech Holdings Inc stock forecast for 2026?
Our models put fair value at $0.0002, about +100% upside versus a price of $0.0001 (undervalued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of Gentech Holdings Inc (GTEH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Gentech Holdings Inc it is $0.0002 per share (as of Sep 27, 2026), against a price of $0.0001. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Gentech Holdings Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, GTEH trades below its calculated fair value: price $0.0001, fair value $0.0002, a gap of about +100% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GTEH?
No. The price is what the market pays today ($0.0001); the fair value is what the company's own numbers justify ($0.0002). For Gentech Holdings Inc the two are $0.0001 per share apart. That gap is exactly why we show both numbers side by side.
How much is Gentech Holdings Inc worth?
The market values Gentech Holdings Inc at about $610 (market capitalisation, as of Sep 27, 2026). Per share that is $0.0001; our models calculate a fair value of $0.0002 per share.
How far is GTEH from its 52-week high?
Gentech Holdings Inc trades at $0.0001, about 100% below its 52-week high of $0.0500 and at the low of $0.0001 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0002 is for.
Which stocks are comparable to Gentech Holdings Inc?
From the same area (Consumer Cyclical) we also value McDonald's Corporation, Starbucks Corporation, Chipotle Mexican Grill, Inc, Yum! Brands, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Gentech Holdings Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0001, calculated fair value $0.0002 (+100%), Quality Score 29/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GTEH calculated?
We run Gentech Holdings Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0002, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Gentech Holdings Inc currently trades 50 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Gentech Holdings Inc (GTEH)?
The closing price on Sep 30, 2026 was $0.0001. Our model-based fair value is $0.0002, about +100% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Gentech Holdings Inc right now?
The large discount to fair value meets weak quality (29/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0002). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Gentech Holdings Inc
How large is the market capitalisation of Gentech Holdings Inc (GTEH)?
The market capitalisation of Gentech Holdings Inc is $610. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Gentech Holdings Inc (GTEH)?
Earnings per share at Gentech Holdings Inc are $−12.68. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of Gentech Holdings Inc (GTEH)?
On an EBIT basis the return on assets of Gentech Holdings Inc is −6,970% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Gentech Holdings Inc (GTEH) generate?
The free cash flow of Gentech Holdings Inc is −$7.9M (fiscal year 2021). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Gentech Holdings Inc (GTEH) carry?
The net debt of Gentech Holdings Inc is $888K (fiscal year 2021). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Gentech Holdings Inc in the live analysis
One click puts Gentech Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026